Business

Time to Reexamine Accountable Care Organizations?
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
A Teachable Moment in Health Benefits Design
Knee and Hip Pain: Rewarding Optimal Long-Term Management
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Saving Money Is Not Always the Objective
Comparing Cost and Utilization of 2 Therapies for Metastatic Castration-Resistant Prostate Cancer
The Rationale for Comparing the Costs of Competing Treatment Options in Oncology
Challenges Surrounding the New Biosimilars Landscape
Page 7 of 15
Results 61 - 70 of 148
Copyright © Engage Healthcare Communications, LLC. All rights reserved.